These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11294046)

  • 1. [How I explore ... the risk of metastasis from melanoma].
    Piérard GE; Arrese JE; Piérard-Franchimont C; Nikkels AF;
    Rev Med Liege; 2001 Feb; 56(2):120-3. PubMed ID: 11294046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
    Wilson LL
    Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma.
    Saltman BE; Ganly I; Patel SG; Coit DG; Brady MS; Wong RJ; Boyle JO; Singh B; Shaha AR; Shah JP; Kraus DH
    Head Neck; 2010 Dec; 32(12):1686-92. PubMed ID: 20848412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    Miranda EP
    J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
    [No Abstract]   [Full Text] [Related]  

  • 5. What sentinel node biopsy in patients with melanoma (or patients whose doctors worry that they could have melanoma) might and might not do.
    LeBoit PE
    Clin Dermatol; 2009; 27(6):588-93. PubMed ID: 19880045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
    Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
    Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy and melanoma biology.
    Essner R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma?
    Satzger I; Meier A; Alter M; Kapp A; Gutzmer R
    J Clin Oncol; 2011 Apr; 29(11):e315; author reply e316-7. PubMed ID: 21383303
    [No Abstract]   [Full Text] [Related]  

  • 14. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
    Dewar DJ; Newell B; Green MA; Topping AP; Powell BW; Cook MG
    J Clin Oncol; 2004 Aug; 22(16):3345-9. PubMed ID: 15310779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
    Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
    Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
    Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
    Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph nodes in cutaneous melanoma.
    Prieto VG
    Clin Lab Med; 2011 Jun; 31(2):301-10. PubMed ID: 21549243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
    Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.